Indicated for: diagnostic imaging
Route of administration: injectable
Substance: radiopharmaceuticals (18F fluorocholine chloride) (contrast agent)
ATC: V09IX07 (Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection)
Fluorocholine chloride (18F) is a radiopharmaceutical used in positron emission tomography (PET) for the diagnosis of prostate cancer and other types of cancer. It works by marking cells with increased metabolic activity, allowing their detection through imaging.
The medication is administered intravenously, as directed by a doctor, usually before the PET scan. It is important for patients to follow all instructions provided before the procedure.
Patients should be aware of potential side effects, such as injection site reactions or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Side effects are rare but may include allergic reactions or discomfort at the injection site. In very rare cases, complications related to radiation exposure may occur. Patients should be informed of these risks before use.